Elite Pharmaceuticals, Inc. ELTP
0.24 USD +0.01 (+2.87%)
Nov 11, 2026, 3:49 PM EST
0.2108 Day range 0.2488
0.21 52-week range 0.69
- YTD
- -51.02%
- 1 year
- -63.08%
Revenue & Expenses
Revenue by
Latest period ending Mar 31, 2023 · select a line to chart its full history
Income statement
| Fiscal year | FY 2023 Mar 31, 2023 | FY 2022 Mar 31, 2022 | FY 2021 Mar 31, 2021 | FY 2020 Mar 31, 2020 | FY 2019 Mar 31, 2019 |
|---|---|---|---|---|---|
| 34.16M | 32.26M | 25.38M | 17.99M | 7.57M | |
| 16.59M | 14.80M | 11.87M | 7.98M | 2.87M | |
| 3.68M | 5.07M | 2.10M | -2.29M | -9.16M | |
| 3.56M | 8.90M | 5.09M | -2.24M | -9.28M |
Balance sheet
| Fiscal year | FY 2023 Mar 31, 2023 | FY 2022 Mar 31, 2022 | FY 2021 Mar 31, 2021 | FY 2020 Mar 31, 2020 | FY 2019 Mar 31, 2019 |
|---|---|---|---|---|---|
| 7.83M | 8.54M | 3.19M | 1.13M | 2.28M | |
| 40.90M | 35.15M | 26.19M | 24.96M | 24.40M | |
| 11.94M | 9.93M | 10.04M | 14.30M | 13.01M | |
| 3.89M | 2.78M | 2.38M | 4.03M | 3.98M | |
| 28.96M | 25.22M | 16.15M | 10.66M | -2.51M |
Cash flow
| Fiscal year | FY 2023 Mar 31, 2023 | FY 2022 Mar 31, 2022 | FY 2021 Mar 31, 2021 | FY 2020 Mar 31, 2020 | FY 2019 Mar 31, 2019 |
|---|---|---|---|---|---|
| 3.34M | 6.51M | 3.19M | -1.79M | -6.79M | |
| -5.74M | -498.57K | -262.78K | -34.95K | 330.87K | |
| 1.70M | -667.13K | -869.83K | 689.54K | 1.57M | |
| -5.74M | -498.57K | -262.78K | -34.95K | -19.13K | |
| -695.72K | 5.34M | 2.06M | -1.14M | -4.90M |